British Pharmaceutical Industry advocates 'light speed' drug development using digital and AI

People are going to suffer harm, even death, if this is not stopped

Hedley Rees

Nov 09, 2023

∙ Paid

Association of the British Pharmaceutical Industry

Subscribers may remember this post from a few days ago:

ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY'S NARRATIVE SENDS CHILLS UP YOUR SPINE

Hedley Rees

November 7, 2023

ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY'S NARRATIVE SENDS CHILLS UP YOUR SPINE

INSIDE PHARMA is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. November 2023 edition of the Pharma Times Please take a minute or two to read the editorial introduction, ‘Familiar foe’ from the November 2023 edition of the

Read full story

As you may know, PharmaTimes Magazine is the ABPIs monthly publication. I began taking my free copy over twenty years ago. Can’t be bothered to cancel it, so I just drop it in the bin/trash every month. This month, for some strange reason, a masochistic urge came over me, and I read the introduction by the editor, John Pinching.

I voted this comment below highest on the chillometer scale:

“Navigating threats at light speed will continue to dictate the narrative, with technology, digital, AI and life sciences taking a leading role…more specifically, doctors and nurses will inevitably embrace ‘the future’ and collaborate with it.”

I’m sure it won’t need translating for you critical thinking subscribers here, but I will add another post from some time ago that you may have forgotten.

INSIDE PHARMA

British Pharmaceutical Industry advocates 'light speed' drug development using digital and AI

People are going to suffer harm, even death, if this is not stopped

Association of the British Pharmaceutical Industry

ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY'S NARRATIVE SENDS CHILLS UP YOUR SPINE

This post is for paid subscribers